Item Type | Name |
Concept
|
Gastroenterology
|
Academic Article
|
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.
|
Academic Article
|
Apolipoprotein synthesis in nonalcoholic steatohepatitis.
|
Academic Article
|
A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection.
|
Academic Article
|
Medical hurricane: health care reform and hepatology.
|
Academic Article
|
Fibrosing NASH: on being a blind man in a dark room looking for a black cat (that isn't there).
|
Academic Article
|
Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease?
|
Academic Article
|
Recurrent and new hepatitis C virus infection after liver transplantation.
|
Academic Article
|
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis.
|
Academic Article
|
Branched chains revisited.
|
Academic Article
|
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
|
Academic Article
|
Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives.
|
Academic Article
|
Predictors of patient and graft survival following liver transplantation for hepatitis C.
|
Academic Article
|
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
|
Academic Article
|
The effect of insulin on human small intestinal mucosal protein synthesis.
|
Academic Article
|
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
|
Academic Article
|
Fetal obesity syndrome: maternal nutrition as a cause of nonalcoholic steatohepatitis.
|
Academic Article
|
Recurrence of primary sclerosing cholangitis following liver transplantation.
|
Academic Article
|
Patient and graft survival following liver transplantation for hepatitis C: much ado about something.
|
Academic Article
|
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
|
Academic Article
|
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
|
Academic Article
|
Introduction to the genetics and biology of interleukin-28B.
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
Academic Article
|
Impact of obesity on treatment of chronic hepatitis C.
|
Academic Article
|
Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis.
|
Academic Article
|
Boceprevir (Victrelis) for HCV: V is for victory and very complex.
|
Academic Article
|
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
|
Academic Article
|
Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice.
|
Academic Article
|
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease.
|
Academic Article
|
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
|
Academic Article
|
Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
|
Academic Article
|
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
Academic Article
|
Genetic susceptibility to hepatitis E viral infection: An enigmatic virus gives up a secret.
|
Academic Article
|
Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey.
|
Academic Article
|
Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation.
|
Academic Article
|
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
|
Academic Article
|
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.
|
Academic Article
|
Reply: To PMID 24824965.
|
Academic Article
|
Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
|
Academic Article
|
Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
|
Academic Article
|
The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.
|
Academic Article
|
Usefulness of Liver Transplantation in the Elderly: The Converging Impact of Risk and Benefit.
|
Academic Article
|
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
|
Academic Article
|
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
|
Academic Article
|
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
|
Academic Article
|
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
|
Academic Article
|
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
|
Academic Article
|
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
|
Academic Article
|
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
|
Academic Article
|
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
|
Academic Article
|
The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis.
|
Academic Article
|
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
|
Academic Article
|
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation.
|
Academic Article
|
Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes.
|
Academic Article
|
Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs.
|
Academic Article
|
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
|